title: Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism.
abstract: Hyperandrogenism and ovulatory dysfunction are common in women with either polycystic ovary (PCOS) or ovarian virilizing tumor. However, contrasting with the numerous studies that have extensively described gonadotropin secretory abnormalities, principally increased LH pulse amplitude and frequency, few studies have concerned gonadotropin secretion in patients with ovarian virilizing tumors; low gonadotropin levels have occasionally been reported, but never extensively studied. The goal of the present study was to further evaluate the pulsatility of LH secretion in women with ovarian virilizing tumor compared with that of PCOS patients. Eighteen women with major hyperandrogenism (plasma testosterone level >1.2 ng/ml) were studied (5 women with ovarian virilizing tumor, 13 women with PCOS, and 10 control women). Mean plasma LH level, LH pulse number and amplitude were dramatically low in patients with ovarian tumors when compared to both PCOS (p<0.001) and controls (p<0.001). In case of major hyperandrogenism, LH pulse pattern differs markedly between women with ovarian virilizing tumor or PCOS, suggesting different mechanisms of hypothalamic or pituitary feedback.
authors.affiliation: Endocrinology, Pitié-Salpétrière Hospital, 83 boulevard de l'Hôpital, 75013, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Bachelot
authors.forename: K
authors.initials: K
authors.lastname: Laborde
authors.forename: J L
authors.initials: JL
authors.lastname: Bresson
authors.forename: G
authors.initials: G
authors.lastname: Plu-Bureau
authors.forename: A
authors.initials: A
authors.lastname: Raynaud
authors.forename: X
authors.initials: X
authors.lastname: Bertagna
authors.forename: A
authors.initials: A
authors.lastname: Mogenet
authors.forename: M
authors.initials: M
authors.lastname: Mansour
authors.forename: V
authors.initials: V
authors.lastname: Lucas-Jouy
authors.forename: J-P
authors.initials: JP
authors.lastname: Gayno
authors.forename: Y
authors.initials: Y
authors.lastname: Reznik
authors.forename: J-M
authors.initials: JM
authors.lastname: Kuhn
authors.forename: L
authors.initials: L
authors.lastname: Billaud
authors.forename: M-C
authors.initials: MC
authors.lastname: Vacher-Lavenu
authors.forename: M
authors.initials: M
authors.lastname: Putterman
authors.forename: I
authors.initials: I
authors.lastname: Mowszowicz
authors.forename: P
authors.initials: P
authors.lastname: Touraine
authors.forename: F
authors.initials: F
authors.lastname: Kuttenn
mesh_terms: D000293:Adolescent; D000328:Adult; D025461:Feedback, Physiological; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D017588:Hyperandrogenism / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000097:blood*; D011085:Polycystic Ovary Syndrome / Q000378:metabolism*; D011673:Pulsatile Flow; D013739:Testosterone / Q000097:blood; D014770:Virilism / Q000378:metabolism*
chemical_list: D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone